Roche Introduces RocheDiabetes InsulinStart to Facilitate the Access to Insulin Therapy for T2D Patients
Shots:
- RocheDiabetes InsulinStart is a service designed to aid patients with T2D with a goal to facilitate the transition from oral antidiabetic therapies to long-term insulin once-daily therapy
- The message-based service supports the patients in the critical phase of finding the optimal dose for insulin (qd). The service will provide the user with the text message in the morning to remind them to take a blood sugar test and in the evening to recommend the insulin dose
- The Roche Diabetes InsulinStart service is offered in integration with Accu-Chek Smart Pix software- allowing doctors to adjust the therapy according to the patient’s need and avoids additional visit at the same time
Click here to read full press release/ article
Ref: Roche | Image: Roche
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com